Increased orbitofrontal cortex activation associated with “pro-obsessive” antipsychotic treatment in patients with schizophrenia

BACKGROUND: Patients with schizophrenia have an approximately 10-fold higher risk for obsessive–compulsive symptoms (OCS) than the general population. A large subgroup seems to experience OCS as a consequence of second-generation antipsychotic agents (SGA), such as clozapine. So far little is known...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Psychiatry Neurosci
Egile Nagusiak: Schirmbeck, Frederike, Mier, Daniela, Esslinger, Christine, Rausch, Franziska, Englisch, Susanne, Eifler, Sarah, Meyer-Lindenberg, Andreas, Kirsch, Peter, Zink, Mathias
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 8872147 Canada Inc. 2015
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354822/
https://ncbi.nlm.nih.gov/pubmed/25268790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/jpn.140021
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak